Cancer Detection AI built for pathologists who want efficient diagnostics
for faster, more accurate cancer detection.
Predictions indicate that the number of new cases of cancer will reach 35 million by 2050 (77% increase)*
With pathologists responsible for diagnosing 100% of all cancers, their workloads are set to increase.
Franklin.ai leverages cutting-edge technology to transform AI Cancer Detection and streamline cancer diagnostics. Its advanced capabilities are especially impactful in the AI detection of prostate cancer. Franklin's AI Cancer Detection AI includes two products designed to support both traditional histopathology workflows and digital pathology systems.
Franklin.ai Digital integrates seamlessly with digital pathology workflows, analysing whole-slide images to identify and flag clinically significant abnormalities. Franklin.ai Glass integrates with traditional histopathology workflows, bringing the power of AI to glass slides without the need for digital scanners.
Designed to support pathologists in managing rising caseloads, Franklin.ai’s Cancer Detection AI models analyse prostate core biopsies (PCB) and TURP chips with exceptional precision. Franklin.ai achieved near-perfect or substantial agreement in significant clinical findings across 1,735 slides reviewed by a panel of 12 subspecialists. By automating routine tasks, flagging areas of concern, and pre-populating reports, Franklin.ai enables pathologists to focus their expertise on complex cases, navigate workloads more efficiently, and deliver timely, confident diagnoses.
Our Cancer Detection AI is designed to assist pathologists in diagnosing a variety of cancer types with speed and precision. By analysing whole-slide images or traditional glass slides, our technology identifies key clinical findings, ensuring that no detail is overlooked.
This adaptable approach supports pathologists in delivering timely and accurate diagnoses across different tissue types, helping to address rising caseloads and improve patient care outcomes. Whether working with complex cases or routine screenings, Franklin.ai's advanced cancer detection AI enhances diagnostic workflows at every stage.
Franklin.ai’s tools provide pathologists with AI-driven insights, highlighting areas of concern and streamlining case reviews. This reduces diagnostic uncertainty and allows healthcare professionals to focus on delivering high-quality patient care.
By integrating cancer detection AI into workflows, Franklin.ai automates routine tasks and pre-populates reports with clinically significant findings, enabling pathologists to allocate more time to complex cases. Our cancer detection AI enhances efficiency and supports laboratories in managing increasing workloads without compromising care standards.
Whether your lab utilizes cutting-edge digital pathology or relies on glass slide analysis, our solutions seamlessly integrate into your workflow. With Franklin.ai’s Cancer Detection AI, pathologists can achieve consistent, reliable results, streamlining workflows and managing increasing caseloads with ease. This ensures both efficiency and precision in delivering high-quality patient care.
Schedule a call with our team to explore how Franklin.ai can revolutionise your lab’s workflow. Lab directors can optimise operational efficiency, while pathologists benefit from advanced cancer detection AI support tailored to prostate cancer diagnostics.